Latest News and Press Releases
Want to stay updated on the latest news?
- 
                            
Boston, Oct. 29, 2025 (GLOBE NEWSWIRE) -- According to the latest study from BCC Research, “mRNA: Therapeutics and Global Markets” is forecast to remain stable or slightly decline to $7.69 billion...
 - 
                            
San Diego, Oct. 16, 2025 (GLOBE NEWSWIRE) -- Endure Biotherapeutics, Inc. (Endure Bio®), a pioneer in engineered engraftable microbial therapeutics, today announced that its founding discovery...
 - 
                            
New York, USA, Oct. 02, 2025 (GLOBE NEWSWIRE) -- CRISPR Therapies Clinical Trial Pipeline Shows Potential with Active Contributions from 25+ Key Companies | DelveInsight CRISPR therapies offer...
 - 
                            
Dublin, Sept. 29, 2025 (GLOBE NEWSWIRE) -- The "Global Biochemicals Market 2026-2036" report has been added to ResearchAndMarkets.com's offering. The global biochemicals market represents one of...
 - 
                            
Dublin, Sept. 26, 2025 (GLOBE NEWSWIRE) -- The "Base Editing Market Size, Share & Trends Analysis Report by Products & Services (Platform, gRNA Design), by Application (Drug Discovery &...
 - 
                            
Dublin, Aug. 29, 2025 (GLOBE NEWSWIRE) -- The "CRISPR Gene Editing in Infectious Diseases: Market Overview" report has been added to ResearchAndMarkets.com's offering.The report provides an...
 - 
                            
BERKELEY, Calif., Aug. 25, 2025 (GLOBE NEWSWIRE) -- Caribou Biosciences, Inc. (Nasdaq: CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical company, today announced Rachel...
 - 
                            
Boston, Aug. 20, 2025 (GLOBE NEWSWIRE) -- According to the latest study from BCC Research, the “Genome Editing: Technologies and Global Markets” is projected to grow from $10.8 billion in 2025 to...
 - 
                            
-- Two robust clinical datasets from CB-010 and CB-011 expected to be disclosed in H2 2025 -- -- $184 million in cash, cash equivalents, and marketable securities expected to fund the Company’s...
 - 
                            
San Diego, Aug. 12, 2025 (GLOBE NEWSWIRE) -- FOR IMMEDIATE RELEASE Endure Biotherapeutics Receives SBIR Phase I Grant to Advance Engineered Native Bacteria Therapy for Familial Adenomatous...